Treatment Action Group

Childhood TB Roadmap to be launched on 1 October in Washington, DC

The World Health Organization, The Union, the Stop TB Partnership, USAID, CDC, the Treatment Action Group and UNICEF will launch a roadmap outlining the path towards zero deaths from childhood tuberculosis.

Read More →

TAG, TB CAB open letter to Alere

Re: Responsible marketing and access plans for Alere’s Determine TB-­LAM antigen test for active TB

Read More →

Treatment Action Group criticizes European refusal of new drug to fight tuberculosis

Approval of and access to delamanid is crucial while further research is pending.

Read More →

TAG, TB CAB open letter to Sequella

Re: Further research into sutezolid urgently needed for tuberculosis

Read More →

TAG, TB CAB, India CAB open letter to Immunoshop

Re: Marketing and use of TB Platinum for active TB in India and high TB burden countries

Read More →

Open letter to Sanofi: Reduce rifapentine cost and increase research funding

Leading doctors, advocacy groups, medical organizations and U.S. TB programs call upon Sanofi to lower the price of rifapentine to ensure its accessibility and continue and expand its investments in the development of the drug for active TB.

Read More →

HIV i-Base/TAG: 2013 Pipeline Report

Survey shows HIV pipeline healthy, HCV drug development surging, while TB research moves forward much too slowly; Faster research, approval, and access demanded.

Read More →

TAG, TB CAB, India CAB open letter to Qiagen

Re: Marketing and use of QuantiFERON-TB Gold for active TB in India and high TB burden countries

Read More →

Treatment Action Group: tagline Spring 2013

The Spring 2013 issue of tagline contains three articles about TB research:

Read More →

Children with drug-resistant tuberculosis require urgent attention

Research and access required to achieve zero deaths, new infections, and suffering

Read More →

Page 8 of 10 · Total posts: 10

←First 7 8 9 Last→